New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
09:24 EDTAET, SQNMSequenom could benefit meaningfully from Aetna decision, says Oppenheimer
After Aetna (AET) recommended measuring cell-free fetal nucleic acids when testing for Down's syndrome in at-risk women, Oppenheimer thinks the recommendation suggests that Aetna is likely to pick up coverage of Sequenom's MaterniT21. The firm reiterates an Outperform rating on Sequenom.
News For SQNM;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
16:36 EDTAETMarket ends week higher as domestic data, foreign central banks boost shares
Subscribe for More Information
14:27 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
14:26 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
November 17, 2014
07:16 EDTAETMilken Institute--Faster Cures to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use